Departamento de Segmento Anterior. Fundación Hospital Nuestra Señora de la Luz, Ciudad de México, México.
Centro de Investigación Biomédica. Fundación Hospital Nuestra Señora de la Luz, Ciudad de México, México.
Cir Cir. 2020;88(3):331-336. doi: 10.24875/CIRU.19001372.
To analyze indicators of social impact in patients with senile cataract treated with phacoemulsification and intraocular lens (IOL) implant.
Patients ≥ 60 years, better corrected visual acuity (BCVA) ≥ 0.6 logarithm of the minimum angle of resolution (LogMAR) and senile cataract treated with PHACO + IOL for cases and incipient senile cataract without surgical treatment with MVCA < 0.6 LogMAR for controls. Exclusion criteria; pathologies that modify the quality of life. The WHOQOL-OLD test was applied: presurgical, one postoperative month and three postoperative months.
54 controls and 56 cases were included. The preoperative BCVA was 1.57 ± 1.041, third month was 0.68 ± 0.7817 (p < 0.001). The results of the preoperative WHOQOL-OLD survey vs the third month: INT 12.96 versus 11.06 (p < 0001); DAD, 10.48 versus 6.389 (p < 0.00001); SOP 12.07 versus 13.76 (p < 0.0007) and SAB, 13.02 versus 8.648 (p < 0.0001). The survey of the 3 month versus the controls: INT 9.66 versus 11.06 (p < 0.001); PPF, 13.89 versus 12.39 (p < 0.001) and AUT 12.47 versus 10.15 (p < 0.001).
Patients, present an improvement in the BCVA that is reflected in the quality of life, this can be interpreted as positive results and should be taken into account to support the surgical indication.
分析行超声乳化白内障吸除术联合人工晶状体(IOL)植入术治疗老年性白内障患者的社会影响指标。
选取年龄≥60 岁、最佳矫正视力(BCVA)≥0.6 对数最小角分辨率(LogMAR)且行 PHACO+IOL 治疗的患者为病例组,以及未经手术治疗但 MVCA<0.6 LogMAR 的初发老年性白内障患者为对照组。排除标准:改变生活质量的病理学改变。应用 WHOQOL-OLD 测试:术前、术后 1 个月和术后 3 个月。
纳入 54 例对照组和 56 例病例组。术前 BCVA 为 1.57±1.041,术后 3 个月为 0.68±0.7817(p<0.001)。术前 WHOQOL-OLD 调查结果与术后 3 个月结果比较:INT 12.96 与 11.06(p<0.001);DAD,10.48 与 6.389(p<0.00001);SOP 12.07 与 13.76(p<0.0007)和 SAB,13.02 与 8.648(p<0.0001)。术后 3 个月与对照组调查结果比较:INT 9.66 与 11.06(p<0.001);PPF,13.89 与 12.39(p<0.001)和 AUT 12.47 与 10.15(p<0.001)。
患者的 BCVA 改善反映了生活质量的提高,这可以被解释为积极的结果,应该考虑作为手术适应证的支持依据。